About LabGenius
LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the discovery of next-generation therapeutic antibodies for solid tumours.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Milestone
Website domain registered
labgeniustx.com
- Capital Raise
Raised $44,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $15,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $10,000,000 · Series-A
- Capital Raise
Raised $4,000,000 · Seed
startupintros.com
- Milestone
X account created (@labgeni_us)
2.6K followers
- Milestone
Company founded
London, United Kingdom
Investors & Backers
Funding History
Founders & Leadership
Angus Sinclair
Chief Scientific Officer
Dr. Didier Landais
Chief Operating Officer
Harry Rickerby
Founder
James Field
Founder
Staffan Piledahl
Software Engineer
Press Coverage & Sources
startupintros.com/news/2024-05-01-labgenius-series-b
fundraisingfox.com/companies/labgenius
startupintros.com/news/2020-10-01-labgenius-series-a-2
techcrunch.com/2019/10/22/labgenius/
startupintros.com/news/2017-11-01-labgenius-seed
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com